GPC
37
-14
VRSK
35
-3
OI
43
-7
BF.B
43
-7
UPS
55
-6
MMM
52
2
ADM
33
-3
ADP
69
-3
EQR
54
-2
PGR
68
3
PPG
61
-5
BBY
56
-2
MDT
53
-2
FRT
36
-2
ISRG
68
-3
FAST
46
-3
KLAC
61
-2
VNO
57
-2
ED
53
4
CL
58
2
GPC
37
-14
VRSK
35
-3
OI
43
-7
BF.B
43
-7
UPS
55
-6
MMM
52
2
ADM
33
-3
ADP
69
-3
EQR
54
-2
PGR
68
3
PPG
61
-5
BBY
56
-2
MDT
53
-2
FRT
36
-2
ISRG
68
-3
FAST
46
-3
KLAC
61
-2
VNO
57
-2
ED
53
4
CL
58
2
Financhill
Back

First Trust NASDAQ-100-Tech Sector ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
65

QTEC
First Trust NASDAQ-100-Tech Sector ETF

Last Price:
187.33
Seasonality Move:
2.99%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
65
First Trust NASDAQ-100-Tech Sector ETF (QTEC) is a Buy

Is First Trust NASDAQ-100-Tech Sector ETF a Buy, Sell or Hold?

  • The current First Trust NASDAQ-100-Tech Sector ETF [QTEC] share price is $187.08. The Score for QTEC is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • QTEC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

QTEC Stock Price Chart

What is First Trust NASDAQ-100-Tech Sector ETF's stock price today?

  • The First Trust NASDAQ-100-Tech Sector ETF share price today is $187.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QTEC is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

QTEC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 53.15 Buy
Chaikin Money Flow: 43664 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (181.5 - 190.54) Buy
Bollinger Bands (100): (181.39 - 197.17) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

QTEC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 185.14 Buy
20-day SMA: 184.7 Buy
50-day SMA: 186.38 Buy
200-day SMA: 185.66 Buy
8-day EMA: 185.17 Buy
20-day EMA: 184.81 Buy
50-day EMA: 186.41 Buy
200-day EMA: 181.14 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

First Trust NASDAQ-100-Tech Sector ETF Earnings Growth & QTEC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

First Trust NASDAQ-100-Tech Sector ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):